Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2016, Article ID 9047821, 13 pages
http://dx.doi.org/10.1155/2016/9047821
Research Article

High Fat Diet-Induced Skeletal Muscle Wasting Is Decreased by Mesenchymal Stem Cells Administration: Implications on Oxidative Stress, Ubiquitin Proteasome Pathway Activation, and Myonuclear Apoptosis

1Laboratorio de Biologia y Fisiopatologia Molecular, Departamento de Ciencias Biologicas, Facultad de Ciencias Biologicas y Facultad de Medicina, Universidad Andres Bello, 8370146 Santiago, Chile
2Millennium Institute on Immunology and Immunotherapy, 8370146 Santiago, Chile
3Departamento de Ciencias Quimicas y Biologicas, Facultad de Salud, Universidad Bernardo O Higgins, 8370993 Santiago, Chile
4Departamento de Gastroenterologıa, Facultad de Medicina, Pontificia Universidad Católica de Chile, 8330024 Santiago, Chile
5Laboratorio de Fisiologia Integrativa, Departamento de Ciencias Biologicas, Facultad de Ciencias Biologicas y Facultad de Medicina, Universidad Andres Bello, 8370146 Santiago, Chile
6Centro de Medicina Regenerativa, Facultad de Medicina, Clinica Alemana, Universidad del Desarrollo, 7710162 Santiago, Chile

Received 17 March 2016; Accepted 14 June 2016

Academic Editor: Saeid Golbidi

Copyright © 2016 Johanna Abrigo et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. T. Jagoe, S. H. Lecker, M. Gomes, and A. L. Goldberg, “Patterns of gene expression in atrophying skeletal muscles: response to food deprivation,” The FASEB Journal, vol. 16, no. 13, pp. 1697–1712, 2002. View at Publisher · View at Google Scholar · View at Scopus
  2. J. L. Bailey, “Insulin resistance and muscle metabolism in chronic kidney disease,” ISRN Endocrinology, vol. 2013, Article ID 329606, 14 pages, 2013. View at Publisher · View at Google Scholar
  3. B. A. Bhatt, J. J. Dube, N. Dedousis, J. A. Reider, and R. M. O'Doherty, “Diet-induced obesity and acute hyperlipidemia reduce IκBα levels in rat skeletal muscle in a fiber-type dependent manner,” American Journal of Physiology—Regulatory Integrative and Comparative Physiology, vol. 290, no. 1, pp. R233–R240, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. B. Sishi, B. Loos, B. Ellis, W. Smith, E. F. Du Toit, and A.-M. Engelbrecht, “Diet-induced obesity alters signalling pathways and induces atrophy and apoptosis in skeletal muscle in a prediabetic rat model,” Experimental Physiology, vol. 96, no. 2, pp. 179–193, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. D. Pette and R. S. Staron, “Myosin isoforms, muscle fiber types, and transitions,” Microscopy Research and Technique, vol. 50, no. 6, pp. 500–509, 2000. View at Publisher · View at Google Scholar · View at Scopus
  6. K. Higashino, T. Matsuura, K. Suganuma, K. Yukata, T. Nishisho, and N. Yasui, “Early changes in muscle atrophy and muscle fiber type conversion after spinal cord transection and peripheral nerve transection in rats,” Journal of NeuroEngineering and Rehabilitation, vol. 10, no. 1, article 46, 2013. View at Publisher · View at Google Scholar · View at Scopus
  7. C. Cabello-Verrugio, M. G. Morales, J. C. Rivera, D. Cabrera, and F. Simon, “Renin-angiotensin system: an old player with novel functions in skeletal muscle,” Medicinal Research Reviews, vol. 35, no. 3, pp. 437–463, 2015. View at Publisher · View at Google Scholar · View at Scopus
  8. S. C. Bodine, E. Latres, S. Baumhueter et al., “Identification of ubiquitin ligases required for skeletal muscle atrophy,” Science, vol. 294, no. 5547, pp. 1704–1708, 2001. View at Publisher · View at Google Scholar · View at Scopus
  9. B. A. Clarke, D. Drujan, M. S. Willis et al., “The E3 ligase MuRF1 degrades myosin heavy chain protein in dexamethasone-treated skeletal muscle,” Cell Metabolism, vol. 6, no. 5, pp. 376–385, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. M. J. Eddins, J. G. Marblestone, K. G. Suresh Kumar et al., “Targeting the ubiquitin E3 ligase MuRF1 to inhibit muscle atrophy,” Cell Biochemistry and Biophysics, vol. 60, no. 1-2, pp. 113–118, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. V. C. Foletta, L. J. White, A. E. Larsen, B. Leger, and A. P. Russell, “The role and regulation of MAFbx/atrogin-1 and MuRF1 in skeletal muscle atrophy,” Pflügers Archiv: European Journal of Physiology, vol. 461, no. 3, pp. 325–335, 2011. View at Publisher · View at Google Scholar
  12. P. G. Arthur, M. D. Grounds, and T. Shavlakadze, “Oxidative stress as a therapeutic target during muscle wasting: considering the complex interactions,” Current Opinion in Clinical Nutrition and Metabolic Care, vol. 11, no. 4, pp. 408–416, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. D. E. Kelley, J. He, E. V. Menshikova, and V. B. Ritov, “Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes,” Diabetes, vol. 51, no. 10, pp. 2944–2950, 2002. View at Publisher · View at Google Scholar · View at Scopus
  14. C. S. Stump, E. J. Henriksen, Y. Wei, and J. R. Sowers, “The metabolic syndrome: role of skeletal muscle metabolism,” Annals of Medicine, vol. 38, no. 6, pp. 389–402, 2006. View at Publisher · View at Google Scholar · View at Scopus
  15. C. Meneses, M. G. Morales, J. Abrigo, F. Simon, E. Brandan, and C. Cabello-Verrugio, “The angiotensin-(1–7)/Mas axis reduces myonuclear apoptosis during recovery from angiotensin II-induced skeletal muscle atrophy in mice,” Pflugers Archiv, vol. 467, pp. 1975–1984, 2015. View at Google Scholar
  16. S. Schrepfer, T. Deuse, H. Reichenspurner, M. P. Fischbein, R. C. Robbins, and M. P. Pelletier, “Stem cell transplantation: the lung barrier,” Transplantation Proceedings, vol. 39, no. 2, pp. 573–576, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. D. G. Phinney and D. J. Prockop, “Concise review: mesenchymal stem/multipotent stromal cells: the state of transdifferentiation and modes of tissue repair—current views,” STEM CELLS, vol. 25, no. 11, pp. 2896–2902, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. R. J. Deans and A. B. Moseley, “Mesenchymal stem cells: biology and potential clinical uses,” Experimental Hematology, vol. 28, no. 8, pp. 875–884, 2000. View at Publisher · View at Google Scholar · View at Scopus
  19. M. J. Hoogduijn, M. G. H. Betjes, and C. C. Baan, “Mesenchymal stromal cells for organ transplantation: different sources and unique characteristics?” Current Opinion in Organ Transplantation, vol. 19, no. 1, pp. 41–46, 2014. View at Publisher · View at Google Scholar · View at Scopus
  20. I. Rasmusson, “Immune modulation by mesenchymal stem cells,” Experimental Cell Research, vol. 312, no. 12, pp. 2169–2179, 2006. View at Publisher · View at Google Scholar · View at Scopus
  21. A. I. Caplan and J. E. Dennis, “Mesenchymal stem cells as trophic mediators,” Journal of Cellular Biochemistry, vol. 98, no. 5, pp. 1076–1084, 2006. View at Publisher · View at Google Scholar · View at Scopus
  22. R. M. Deacon, “Measuring the strength of mice,” Journal of Visualized Experiments, no. 76, article e2610, 2013. View at Publisher · View at Google Scholar
  23. M. G. Morales, H. Olguín, G. Di Capua, E. Brandan, F. Simon, and C. Cabello-Verrugio, “Endotoxin-induced skeletal muscle wasting is prevented by angiotensin-(1–7) through a p38 MAPK-dependent mechanism,” Clinical Science, vol. 129, no. 6, pp. 461–476, 2016. View at Publisher · View at Google Scholar · View at Scopus
  24. C. Cabello-Verrugio, M. G. Morales, D. Cabrera, C. P. Vio, and E. Brandan, “Angiotensin II receptor type 1 blockade decreases CTGF/CCN2-mediated damage and fibrosis in normal and dystrophic skeletal muscles,” Journal of Cellular and Molecular Medicine, vol. 16, no. 4, pp. 752–764, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. M. G. Morales, D. Cabrera, C. Céspedes et al., “Inhibition of the angiotensin-converting enzyme decreases skeletal muscle fibrosis in dystrophic mice by a diminution in the expression and activity of connective tissue growth factor (CTGF/CCN-2),” Cell and Tissue Research, vol. 353, no. 1, pp. 173–187, 2013. View at Publisher · View at Google Scholar · View at Scopus
  26. M. G. Morales, C. Cabello-Verrugio, C. Santander, D. Cabrera, R. Goldschmeding, and E. Brandan, “CTGF/CCN-2 over-expression can directly induce features of skeletal muscle dystrophy,” The Journal of Pathology, vol. 225, no. 4, pp. 490–501, 2011. View at Publisher · View at Google Scholar · View at Scopus
  27. P. Gregorevic, D. R. Plant, K. S. Leeding, L. A. Bach, and G. S. Lynch, “Improved contractile function of the mdx dystrophic mouse diaphragm muscle after insulin-like growth factor-I administration,” The American Journal of Pathology, vol. 161, no. 6, pp. 2263–2272, 2002. View at Publisher · View at Google Scholar · View at Scopus
  28. F. Cisternas, M. G. Morales, C. Meneses et al., “Angiotensin-(1–7) decreases skeletal muscle atrophy induced by angiotensin II through a Mas receptor-dependent mechanism,” Clinical Science, vol. 128, no. 5, pp. 307–319, 2015. View at Publisher · View at Google Scholar · View at Scopus
  29. C. Meneses, M. G. Morales, J. Abrigo, F. Simon, E. Brandan, and C. Cabello-Verrugio, “The angiotensin-(1–7)/Mas axis reduces myonuclear apoptosis during recovery from angiotensin II-induced skeletal muscle atrophy in mice,” Pflugers Archiv—European Journal of Physiology, vol. 467, no. 9, pp. 1975–1984, 2015. View at Publisher · View at Google Scholar · View at Scopus
  30. M. G. Morales, J. Abrigo, C. Meneses, F. Cisternas, F. Simon, and C. Cabello-Verrugio, “Expression of the Mas receptor is upregulated in skeletal muscle wasting,” Histochemistry and Cell Biology, vol. 143, no. 2, pp. 131–141, 2014. View at Publisher · View at Google Scholar · View at Scopus
  31. J. Abrigo, J. C. Rivera, F. Simon, D. Cabrera, and C. Cabello-Verrugio, “Transforming growth factor type beta (TGF-β) requires reactive oxygen species to induce skeletal muscle atrophy,” Cellular Signalling, vol. 28, no. 5, pp. 366–376, 2016. View at Publisher · View at Google Scholar · View at Scopus
  32. N. H. Le, C.-S. Kim, T. Park et al., “Quercetin protects against obesity-induced skeletal muscle inflammation and atrophy,” Mediators of Inflammation, vol. 2014, Article ID 834294, 10 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  33. S.-R. Lee, A. V. Khamoui, E. Jo et al., “Effects of chronic high-fat feeding on skeletal muscle mass and function in middle-aged mice,” Aging Clinical and Experimental Research, vol. 27, no. 4, pp. 403–411, 2015. View at Publisher · View at Google Scholar · View at Scopus
  34. Y. Shpilberg, J. L. Beaudry, A. D'Souza, J. E. Campbell, A. Peckett, and M. C. Riddell, “A rodent model of rapid-onset diabetes induced by glucocorticoids and high-fat feeding,” Disease Models and Mechanisms, vol. 5, no. 5, pp. 671–680, 2012. View at Publisher · View at Google Scholar · View at Scopus
  35. I. Peluso and M. Palmery, “The relationship between body weight and inflammation: lesson from anti-TNF-α antibody therapy,” Human Immunology, vol. 77, no. 1, pp. 47–53, 2016. View at Publisher · View at Google Scholar · View at Scopus
  36. H. Khodabandehloo, S. Gorgani-Firuzjaee, G. Panahi, and R. Meshkani, “Molecular and cellular mechanisms linking inflammation to insulin resistance and β-cell dysfunction,” Translational Research, vol. 167, no. 1, pp. 228–256, 2016. View at Publisher · View at Google Scholar · View at Scopus
  37. P. Plomgaard, A. R. Nielsen, C. P. Fischer et al., “Associations between insulin resistance and TNF-α in plasma, skeletal muscle and adipose tissue in humans with and without type 2 diabetes,” Diabetologia, vol. 50, no. 12, pp. 2562–2571, 2007. View at Publisher · View at Google Scholar · View at Scopus
  38. Y.-P. Li, Y. Chen, J. John et al., “TNF-α acts via p38 MAPK to stimulate expression of the ubiquitin ligase atrogin1/MAFbx in skeletal muscle,” FASEB Journal, vol. 19, no. 3, pp. 362–370, 2005. View at Publisher · View at Google Scholar · View at Scopus
  39. N. Carbó, S. Busquets, M. van Royen, B. Alvarez, F. J. López-Soriano, and J. M. Argilés, “TNF-α is involved in activating DNA fragmentation in skeletal muscle,” British Journal of Cancer, vol. 86, no. 6, pp. 1012–1016, 2002. View at Publisher · View at Google Scholar · View at Scopus
  40. Y. Hao, J. R. Jackson, Y. Wang, N. Edens, S. L. Pereira, and S. E. Alway, “β-hydroxy-β-methylbutyrate reduces myonuclear apoptosis during recovery from hind limb suspension-induced muscle fiber atrophy in aged rats,” American Journal of Physiology—Regulatory Integrative and Comparative Physiology, vol. 301, no. 3, pp. R701–R715, 2011. View at Publisher · View at Google Scholar · View at Scopus
  41. S. J. Lessard, D. A. Rivas, K. So et al., “The AMPK-related kinase SNARK regulates muscle mass and myocyte survival,” The Journal of Clinical Investigation, vol. 126, no. 2, pp. 560–570, 2016. View at Publisher · View at Google Scholar · View at Scopus
  42. X. Fu, M. Zhu, S. Zhang, M. Foretz, B. Viollet, and M. Du, “Obesity impairs skeletal muscle regeneration through inhibition of AMPK,” Diabetes, vol. 65, no. 1, pp. 188–200, 2016. View at Publisher · View at Google Scholar
  43. M. L. Messi, T. Li, Z. M. Wang, A. P. Marsh, B. Nicklas, and O. Delbono, “Resistance training enhances skeletal muscle innervation without modifying the number of satellite cells or their myofiber association in obese older adults,” Journals of Gerontology Series A: Biological Sciences and Medical Sciences, 2015. View at Google Scholar
  44. F. S. Tedesco, A. Dellavalle, J. Diaz-Manera, G. Messina, and G. Cossu, “Repairing skeletal muscle: regenerative potential of skeletal muscle stem cells,” The Journal of Clinical Investigation, vol. 120, no. 1, pp. 11–19, 2010. View at Publisher · View at Google Scholar · View at Scopus
  45. A. Bareja and A. N. Billin, “Satellite cell therapy—from mice to men,” Skeletal Muscle, vol. 3, article 2, 2013. View at Publisher · View at Google Scholar · View at Scopus
  46. J. Gao, J. E. Dennis, R. F. Muzic, M. Lundberg, and A. I. Caplan, “The dynamic in vivo distribution of bone marrow-derived mesenchymal stem cells after infusion,” Cells Tissues Organs, vol. 169, no. 1, pp. 12–20, 2001. View at Publisher · View at Google Scholar · View at Scopus
  47. R. H. Lee, A. A. Pulin, M. J. Seo et al., “Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6,” Cell Stem Cell, vol. 5, no. 1, pp. 54–63, 2009. View at Publisher · View at Google Scholar · View at Scopus
  48. S. Jose, M. L. Hughbanks, B. Y. K. Binder, G. C. Ingavle, and J. K. Leach, “Enhanced trophic factor secretion by mesenchymal stem/stromal cells with Glycine-Histidine-Lysine (GHK)-modified alginate hydrogels,” Acta Biomaterialia, vol. 10, no. 5, pp. 1955–1964, 2014. View at Publisher · View at Google Scholar · View at Scopus
  49. S. Chen, J. Murphy, R. Toth, D. G. Campbell, N. A. Morrice, and C. Mackintosh, “Complementary regulation of TBC1D1 and AS160 by growth factors, insulin and AMPK activators,” Biochemical Journal, vol. 409, no. 2, pp. 449–459, 2008. View at Publisher · View at Google Scholar · View at Scopus
  50. S. Yamada, N. Buffinger, J. DiMario, and R. C. Strohman, “Fibroblast growth factor is stored in fiber extracellular matrix and plays a role in regulating muscle hypertrophy,” Medicine and Science in Sports and Exercise, vol. 21, no. 5, pp. S173–S180, 1989. View at Google Scholar · View at Scopus
  51. P. Rocheteau, L. Chatre, D. Briand et al., “Sepsis induces long-term metabolic and mitochondrial muscle stem cell dysfunction amenable by mesenchymal stem cell therapy,” Nature Communications, vol. 6, article 10145, 2015. View at Publisher · View at Google Scholar · View at Scopus
  52. A. W. B. Joe, L. Yi, A. Natarajan et al., “Muscle injury activates resident fibro/adipogenic progenitors that facilitate myogenesis,” Nature Cell Biology, vol. 12, no. 2, pp. 153–163, 2010. View at Publisher · View at Google Scholar · View at Scopus
  53. M. D. Boppart, M. D. Lisio, K. Zou, and H. D. Huntsman, “Defining a role for non-satellite stem cells in the regulation of muscle repair following exercise,” Frontiers in Physiology, vol. 4, article 310, 2013. View at Publisher · View at Google Scholar · View at Scopus
  54. M. Debnath, S. Agrawal, A. Agrawal, and G. P. Dubey, “Metaflammatory responses during obesity: pathomechanism and treatment,” Obesity Research & Clinical Practice, vol. 10, no. 2, pp. 103–113, 2016. View at Publisher · View at Google Scholar
  55. S. Cohen, J. A. Nathan, and A. L. Goldberg, “Muscle wasting in disease: molecular mechanisms and promising therapies,” Nature Reviews Drug Discovery, vol. 14, no. 1, pp. 58–74, 2015. View at Publisher · View at Google Scholar · View at Scopus